American Oncology Network, Inc. Class A Common Stock
AONC
AONC was delisted on the 7th of June, 2024.
13 hedge funds and large institutions have $18.4M invested in American Oncology Network, Inc. Class A Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
2% more capital invested
Capital invested by funds: $18.1M → $18.4M (+$310K)
0% more funds holding
Funds holding: 13 → 13 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$666K |
| 2 |
MSU
Mizuho Securities USA
New York
|
+$498K |
| 3 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$439K |
| 4 |
CS
Clear Street
New York
|
+$22.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
-$1.29M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$33.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$17.3K |
| 4 |
KIM
Karpus Investment Management
Pittsford,
New York
|
-$3.85K |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$1.18K |
AONC Hedge Fund Activity: Q2 2023 in Review
13 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Class A Common Stock (AONC) for Q2 2023, worth a combined $18.4M — up 1.7% from $18.1M a quarter earlier.
Fund positioning in AONC was balanced in Q2 2023: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Cowen and Company, opening a new position worth an estimated $666K. The largest seller was Glazer Capital LLC, exiting entirely with an estimated $1.29M sold.
- 13 institutional investors held American Oncology Network, Inc. Class A Common Stock (AONC) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $18.4M of American Oncology Network, Inc. Class A Common Stock stock for Q2 2023, up 1.7% quarter-over-quarter.
- 3 funds opened new American Oncology Network, Inc. Class A Common Stock positions in Q2 2023 and 3 closed out, a net change of 0 holders.
- The largest American Oncology Network, Inc. Class A Common Stock buyer in Q2 2023 was Cowen and Company, an estimated $666K added.
- The largest American Oncology Network, Inc. Class A Common Stock seller in Q2 2023 was Glazer Capital LLC, an estimated $1.29M sold.
Based on aggregated 13F filings for Q2 2023.